The nasal spray ... allergy. It should be seen as a rescue, but additional treatment may be needed in the ER," Gounder said. Gounder says the drug is meant to be available about eight weeks from ...
The Neffy nasal spray uses the same formula used in the traditional Epinephrine injection as a treatment for mild to severe ...
FDA officials say this is the first epinephrine product for anaphylaxis that is not administered with a needle.
ARS Pharmaceuticals won Food and Drug Administration approval of its neffy nasal spray for the emergency treatment of allergic reactions, including life-threatening anaphylaxis. The FDA on Friday ...
The Food and Drug Administration approved Friday a nasal spray for serious ... injections," Kelly Stone, FDA's associate director of the Division of Pulmonology, Allergy and Critical Care, said ...
According to ARS, the FDA regulators decided at the time that more data was needed to evaluate the safety of repeated doses of the nasal spray before it could be approved. "Neffy is epinephrine ...
allergy, and critical care in the FDA’s Center for Drug Evaluation and Research, in a statement. “The availability of epinephrine nasal spray may reduce barriers to rapid treatment of ...
a director for the FDA’s Center for Drug Evaluation and Research. Neffy is a single-dose nasal spray approved by drugmaker ARS Pharmaceuticals Inc. that administers epinephrine, the only life ...
